目的 研究极早产儿存活率和严重并发症发生情况，并分析其影响因素。 方法 回顾性收集2018年1月至2019年12月江苏省11家医院新生儿科收治的极早产儿（胎龄<32周）的一般资料，分析其存活率和严重并发症发生情况，采用多因素logistic回归分析评估极早产儿死亡和严重并发症发生的危险因素。 结果 共纳入极早产儿2 339例，其中存活2 010例（85.93%），无严重并发症存活1 507例（64.43%）。胎龄22~25+6周、26~26+6周、27~27+6周、28~28+6周、29~29+6周、30~30+6周、31~31+6周各组极早产儿存活率分别是32.5%、60.6%、68.0%、82.9%、90.1%、92.3%、94.8%，随着胎龄增加，存活率呈升高趋势（P<0.05）；相同胎龄分组下无严重并发症存活率分别是7.5%、18.1%、34.5%、52.2%、66.7%、75.7%、81.8%，随着胎龄增加，无严重并发症存活率呈升高趋势（P<0.05）。多因素logistic回归分析显示，胎龄大、出生体重大、母亲产前使用糖皮质激素是极早产儿死亡的保护因素（P<0.05），而1 min Apgar评分≤3分是极早产儿死亡的危险因素（P<0.05）；胎龄大、出生体重大是存活极早产儿发生严重并发症的保护因素（P<0.05），而5 min Apgar评分≤3分、母亲绒毛膜羊膜炎是存活极早产儿发生严重并发症的危险因素（P<0.05）。 结论 极早产儿存活率与胎龄密切相关。1 min Apgar评分≤3分可增加极早产儿死亡的风险，而胎龄大、出生体重大、母亲产前使用糖皮质激素与死亡风险降低有关。5 min Apgar评分≤3分和母亲绒毛膜羊膜炎可增加极早产儿严重并发症发生的风险，而胎龄大、出生体重大可降低严重并发症发生的风险。
Abstract
Objective To study the survival rate and the incidence of complications of very preterm infants and the factors influencing the survival rate and the incidence of complications. Methods The medical data of the very preterm infants with a gestational age of <32 weeks and who were admitted to the Department of Neonatology in 11 hospitals of Jiangsu Province in China from January 2018 to December 2019 were retrospectively reviewed. Their survival rate and the incidence of serious complications were analyzed. A multivariate logistic regression analysis was used to evaluate the risk factors for death and serious complications in very preterm infants. Results A total of 2 339 very preterm infants were enrolled, among whom 2 010 (85.93%) survived and 1 507 (64.43%) survived without serious complications. The groups with a gestational age of 22-25+6 weeks, 26-26+6 weeks, 27-27+6 weeks, 28-28+6 weeks, 29-29+6 weeks, 30-30+6 weeks, and 31-31+6 weeks had a survival rate of 32.5%, 60.6%, 68.0%, 82.9%, 90.1%, 92.3%, and 94.8% respectively. The survival rate tended to increase with the gestational age (P<0.05) and the survival rate without serious complications in each gestational age group was 7.5%, 18.1%, 34.5%, 52.2%, 66.7%, 75.7%, and 81.8% respectively, suggesting that the survival rate without serious complications increased with the gestational age (P<0.05). The multivariate logistic regression analysis showed that high gestational age, high birth weight, and prenatal use of glucocorticoids were protective factors against death in very preterm infants (P<0.05), and 1-minute Apgar score ≤3 was a risk factor for death in very preterm infants (P<0.05); high gestational age and high birth weight were protective factors against serious complications in very preterm infants who survived (P<0.05), while 5-minute Apgar score ≤3 and maternal chorioamnionitis were risk factors for serious complications in very preterm infants who survived (P<0.05). Conclusions The survival rate is closely associated with gestational age in very preterm infants. A low 1-minute Apgar score (≤3) may increase the risk of death in very preterm infants, while high gestational age, high birth weight, and prenatal use of glucocorticoids are associated with the reduced risk of death. A low 5-minute Apgar score (≤3) and maternal chorioamnionitis may increase the risk of serious complications in these infants, while high gestational age and high birth weight may reduce the risk of serious complications.
关键词
存活率 /
并发症 /
危险因素 /
极早产儿
Key words
Survival rate /
Complication /
Risk factor /
Very preterm birth infant
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
1 Wang DN, Yasseen AS, Marchand-Martin L, et al. A population-based comparison of preterm neonatal deaths (22-34 gestational weeks) in France and Ontario: a cohort study[J]. CMAJ Open, 2019, 7(1): E159-E166. DOI: 10.9778/cmajo.20180199. PMID: 30872267. PMCID: PMC6420330.
2 Xu FD, Kong XY, Duan SY, et al. Care practices, morbidity and mortality of preterm neonates in China, 2013-2014: a retrospective study[J]. Sci Rep, 2019, 9(1): 19863. DOI: 10.1038/s41598-019-56101-x. PMID: 31882629. PMCID: PMC6934849.
3 Jiang SY, Yan WL, Li SJ, et al. Mortality and morbidity in infants <34 weeks' gestation in 25 NICUs in China: a prospective cohort study[J]. Front Pediatr, 2020, 8: 33. DOI: 10.3389/fped.2020.00033. PMID: 32117838. PMCID: PMC7031923.
4 Hee Chung E, Chou J, Brown KA. Neurodevelopmental outcomes of preterm infants: a recent literature review[J]. Transl Pediatr, 2020, 9(Suppl 1): S3-S8. DOI: 10.21037/tp.2019.09.10. PMID: 32206579. PMCID: PMC7082240.
5 Bellodas Sanchez J, Kadrofske M. Necrotizing enterocolitis[J]. Neurogastroenterol Motil, 2019, 31(3): e13569. DOI: 10.1111/nmo.13569. PMID: 30793842.
6 朱艳萍, 蒋思远, 王晓康, 等. 中国多中心新生儿重症监护室胎龄小于34周早产儿出院前视网膜病变发生率的横断面调查[J]. 中国循证儿科杂志, 2020, 15(1): 45-49. DOI: 10.3969/j.issn.1673-5501.2020.01.011.
7 谢幸, 苟文丽. 妇产科学[M]. 8版. 北京: 人民卫生出版社, 2013: 47-141.
8 邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 4版. 北京: 人民卫生出版社, 2011: 340-347.
9 Bolisetty S, Legge N, Bajuk B, et al. Preterm infant outcomes in New South Wales and the Australian Capital Territory[J]. J Paediatr Child Health, 2015, 51(7): 713-721. DOI: 10.1111/jpc.12848. PMID: 25644196.
10 Kong XY, Xu FD, Wu R, et al. Neonatal mortality and morbidity among infants between 24 to 31 complete weeks: a multicenter survey in China from 2013 to 2014[J]. BMC Pediatr, 2016, 16(1): 174. DOI: 10.1186/s12887-016-0716-5. PMID: 27809893. PMCID: PMC5094017.
11 Kim JK, Chang YS, Sung S, et al. Mortality rate-dependent variations in the survival without major morbidities rate of extremely preterm infants[J]. Sci Rep, 2019, 9(1): 7371. DOI: 10.1038/s41598-019-43879-z. PMID: 31089251. PMCID: PMC6517394.
12 Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD neonatal research network[J]. Pediatrics, 2010, 126(3): 443-456. DOI: 10.1542/peds.2009-2959. PMID: 20732945. PMCID: PMC2982806.
13 Lee SK, Beltempo M, McMillan DD, et al. Outcomes and care practices for preterm infants born at less than 33 weeks' gestation: a quality-improvement study[J]. CMAJ, 2020, 192(4): E81-E91. DOI: 10.1503/cmaj.190940. PMID: 31988152. PMCID: PMC6989018.
14 Cao Y, Jiang S, Zhou Q. Introducing evidence-based practice improvement in Chinese neonatal intensive care units[J]. Trans Pediatr, 2019, 8(3):257-261. DOI: 10.21037/tp.2019.07.07. PMID: 31413959. PMCID: PMC6675685.
15 Edstedt Bonamy AK, Zeitlin J, Piedvache A, et al. Wide variation in severe neonatal morbidity among very preterm infants in European regions[J]. Arch Dis Child Fetal Neonatal Ed, 2019, 104(1): F36-F45. DOI: 10.1136/archdischild-2017-313697. PMID: 29353260. PMCID: PMC6762001.
16 Ancel PY, Goffinet F, EPIPAGE-2 Writing Group,et al. Survival and morbidity of preterm children born at 22 through 34 weeks' gestation in France in 2011: results of the EPIPAGE-2 cohort study[J]. JAMA Pediatr, 2015, 169(3): 230-238. DOI: 10.1001/jamapediatrics.2014.3351. PMID: 25621457.
17 孔祥永, 张珊, 封志纯, 等. 中国14家医院超/极早产儿早期预后的多中心调查[J]. 中国医刊, 2018, 53(12): 1356-1362. DOI: 10.3969/j.issn.1008-1070.2018.12.015.
18 马俊苓, 高琦, 刘鸽, 等. 超早产儿早产儿视网膜病变的发病情况及危险因素分析[J]. 中华眼底病杂志, 2021, 37(1): 40-46. DOI: 10.3760/cma.j.cn511434-20191011-00325.
19 林丽, 黄继谦, 诸葛张明, 等. 超低出生体重儿243例存活率和并发症临床分析[J]. 中华新生儿科杂志(中英文), 2017, 32(4): 259-263. DOI: 10.3760/cma.j.issn.2096-2932.2017.04.005.
20 Randis TM, Rice MM, Myatt L, et al. Incidence of early-onset sepsis in infants born to women with clinical chorioamnionitis[J]. J Perinat Med, 2018, 46(8): 926-933. DOI: 10.1515/jpm-2017-0192. PMID: 29791315. PMCID: PMC6177287.
21 Victora JD, Silveira MF, Tonial CT, et al. Prevalence, mortality and risk factors associated with very low birth weight preterm infants: an analysis of 33 years[J]. J Pediatr (Rio J), 2020, 96(3): 327-332. DOI: 10.1016/j.jped.2018.10.011. PMID: 30550758.
22 Villamor-Martinez E, Fumagalli M, Mohammed Rahim O, et al. Chorioamnionitis is a risk factor for intraventricular hemorrhage in preterm infants: a systematic review and Meta-Analysis[J]. Front Physiol, 2018, 9: 1253. DOI: 10.3389/fphys.2018.01253. PMID: 30271352. PMCID: PMC6142185.
23 Shah PS, Lui K, Sj?rs G, et al. Neonatal outcomes of very low birth weight and very preterm neonates: an international comparison[J]. J Pediatr, 2016, 177: 144-152.e6. DOI: 10.1016/j.jpeds.2016.04.083. PMID: 27233521.
基金
国家自然科学基金（81971427）；南京市医学科技发展基金（ZKX19045）；江苏省妇幼健康重点人才（FRC201740）；江苏“六个一工程”拔尖人才（LGY2019008）。
PDF(597 KB)
